Cantor Fitzgerald Maintains Overweight on Progyny, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on Progyny (NASDAQ:PGNY) but lowers the price target from $37 to $25.
September 19, 2024 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cantor Fitzgerald's analyst Sarah James maintains an Overweight rating on Progyny but reduces the price target from $37 to $25, indicating a more cautious outlook.
The reduction in the price target from $37 to $25 suggests a less optimistic view on Progyny's future performance, which could lead to a short-term negative impact on the stock price. However, the maintained Overweight rating indicates continued confidence in the stock's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100